RemainCo

Teleflex (RemainCo) is a leading global provider of medical technologies designed to improve the health and quality of people's lives. Following its 2025-2026 corporate separation, the company focuses on high-growth, high-acuity emergent procedures performed primarily in hospital settings, including the Intensive Care Unit, Emergency Department, and Catheter Lab. Its core business segments include Vascular Access, Interventional, and Surgical, featuring a portfolio of diagnostic and therapeutic devices for coronary and peripheral vascular diseases. The company significantly expanded its interventional capabilities through the 2025 acquisition of Biotronik's Vascular Intervention business. Teleflex remains a major player in the medtech industry with a streamlined operating model focused on hospital-based innovation.